Posts Tagged ‘embargo breaks’

PNAS is lifting the embargo early on the following paper. All other articles are under the scheduled embargo:

Glucose, fructose, and appetite

Fructose may enhance the reward value of high-calorie food and promote eating, compared with glucose, according to a study. Differences in metabolism of fructose and glucose may lead to differential effects on physiological and behavioral responses to food. To assess the different effects of the two sugars on hunger and food cue responses in the brain, Kathleen A. Page and colleagues conducted fMRI scans on 24 people who had been given drinks sweetened with fructose on one day and glucose on another day.

The Sunday Times has broken another embargo, this one of a study on a higher risk of birth abnormalities among babies conceived through assisted fertility treatments. The study is scheduled to be presented tomorrow (Monday) at the European Society of Human Genetics meeting in Gothenburg, Sweden, and was embargoed until a minute after midnight Central European Time Monday. The Sunday Times story, by Jonathan Leake, was posted sometime late Saturday.

However, according to from Mary Rice, who is handling media relations on the study, there’s more to the embargo break. In an email sent to her press list at 5:34 a.m. Eastern today, she wrote: Read the rest of this entry »

The embargo should be lifting in two minutes, at 1 p.m. Eastern, on a study in Clinical Cancer Research which found that lowering stress among women with breast cancer was linked to better outcomes. But an item about the study went live on CNN’s Paging Dr. Gupta blog at 10 a.m. Eastern.

Jeff Grabmeier, director of research communications at Ohio State University, where the study’s lead researcher works, emailed me about the break a bit before noon. He said a local reporter had come across the CNN item. Jeff called the American Association for Cancer Research (AACR), the journal’s publisher, and a press officer there told him that they’d contact CNN to see if they could take down the item. Read the rest of this entry »

When it rains, it pours, at least when it comes to embargo breaks, apparently. While I was conducting this interview with Daniel Carlat between noon and one today, two notices about early embargo lifts went out. One was about this ASCO Rituxan break, and here’s the other:

The AAAS Office of Public Programs is lifting the embargo, effective immediately, on the Science article “Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome,” by D. Gibson and colleagues, because this information has entered the public domain.

A summary of the article follows, and a copy of the manuscript is available at http://www.eurekalert.org/jrnls/sci/. The embargo is being lifted so that reporters may freely publish their coverage now. The rest of this week’s SciPak content will remain under embargo until 2 pm US ET today, 20 May.

It’s ASCO time, with the embargo on most conference abstracts lifting tonight at 6 p.m. Eastern, and the media circus has already tossed off one embargo break, according to an email sent out at 12:20 Eastern:

Due to an embargo break, the American Society of Clinical Oncology (ASCO) has lifted the embargo on the abstract titled, “Rituximab maintenance for 2 years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy.”

Reporters are free to publish stories on this study, which was supposed to be embargoed until 6:00 PM (EDT) today.A media summary of the study is copied below, along with the abstract. ASCO is investigating the reasons for this embargo break.